← SynDRA
UPROSERTIB
SynDRA canonical compound SYN0037866 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AKT1 | AKT2 | AKT3 |
| Mechanism of action | AKT inhibitor |
All known targets
Mechanisms of action (all sources)
- AKT2 INHIBITOR
- Serine/threonine-protein kinase AKT inhibitor
- AKT3 INHIBITOR
- AKT1 INHIBITOR
- AKT3 MODULATOR
Cross-references
Synonyms
- Akt inhibitor gsk-2141795
- Akt inhibitor gsk2141795
- Gsk-2141795
- GSK-2141795C
- GSK2141795
- GSK2141795C
- UNII-ZXM835LQ5E
- Uprosertib (GSK2141795)
- ZXM835LQ5E
- GSK795
- GSK-2141795
- 2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
- Uprosertib [USAN:INN]
- Uprosertib (USAN/INN)
- Uprosertib, GSK2141795
- SCHEMBL168584
- GTPL7902
- CHEMBL3137336
- MolPort-044-560-307
- AXTAPYRUEKNRBA-JTQLQIEISA-N
- N-((S)-1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- 2-Furancarboxamide, N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
- N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide
- N-((1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-[(1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- Uprosertib [USAN]
- UPROSERTIB [INN]
- UPROSERTIB [WHO-DD]
- BCP28204
- EX-A1593
- BDBM50170284
- MFCD28144686
- NSC778368
- NSC800960
- s7492
- ZINC43197676
- AKOS027323909
- CCG-268992
- DB11969
Look up UPROSERTIB in the interactive SynDRA portal →